MapLight Therapeutics, Inc. (MPLT) › Cash & EquivalentsMapLight Therapeutics, Inc. (MPLT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $38.25M2025: $46.73M$46.73M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$46.73M+22.2%2024$38.25M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share